Stock ITOS ITEOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart iTeos Therapeutics, Inc.

Equities

ITOS

US46565G1040

Real-time Estimate Cboe BZX
Other stock markets
 03:28:38 2024-07-17 pm EDT 		5-day change 1st Jan Change
16.94 USD -3.53% Intraday chart for iTeos Therapeutics, Inc. +11.02% +54.61%
Jul. 08 ITeos Therapeutics Doses First Patient in Phase 3 Trial of Belrestotug With Dostarlimab; Triggers $35 Million GSK Payment MT
Jul. 08 ITeos Therapeutics, Inc. Announces First Patient Dosed in Galaxies Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ITEOS THERAPEUTICS, INC. Stock iTeos Therapeutics, Inc.
 654M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 118B
ARGENX SE Stock argenx SE
 27.87B -
BIONTECH SE Stock BioNTech SE
 20.95B -
GENMAB A/S Stock Genmab A/S
 16.92B
  1. Stock Market
  2. Equities
  3. ITOS Stock
  4. Charts iTeos Therapeutics, Inc.
  5. Sector Chart